35057 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 08
17:14 UTC
|
LGN
LGN
|
◎ Target | Brian Brophy ★☆☆☆☆ #3142 | Buy | $101.00→ $82.00-18.8% |
|
Oct 08
17:14 UTC
|
KNX
Knight-Swift Transportation
|
◎ Target | J. Bruce Chan ★★★☆☆ #2235 | Buy | $88.00→ $90.00+2.3% |
|
Oct 08
17:14 UTC
|
HCC
Warrior Met Coal
|
◎ Target | George Eadie ★★★☆☆ #1496 | Buy | $98.00→ $102.00+4.1% |
|
Oct 08
17:14 UTC
|
FWRD
Forward Air
|
◎ Target | J. Bruce Chan ★★★☆☆ #2235 | Buy | $27.00→ $24.00-11.1% |
|
Oct 08
17:14 UTC
|
FDXF
FedEx Freight
|
◎ Target | Bruce Chan not yet tracked | Hold | $160.00→ $129.00-19.4% |
|
Oct 08
17:14 UTC
|
FCX
Freeport-McMoRan
|
◎ Target | Daniel Major ★★★☆☆ #1478 | Buy | $77.00→ $88.00+14.3% |
|
Oct 08
17:14 UTC
|
CVX
Chevron
|
◎ Target | Josh Silverstein ★★★☆☆ #1439 | Buy | $220.00→ $235.00+6.8% |
|
Oct 08
17:14 UTC
|
ARCB
ArcBest
|
◎ Target | J. Bruce Chan ★★★☆☆ #2235 | Buy | $185.00→ $168.00-9.2% |
|
Oct 08
17:14 UTC
|
AMR
Alpha Metallurgical Resources
|
◎ Target | George Eadie ★★★☆☆ #1496 | Neutral | $160.00→ $180.00+12.5% |
|
Oct 08
16:14 UTC
|
UTHR
United Therapeutics
|
◎ Target | Lisa Walter ★★☆☆☆ #2426 | Outperform | $677.00→ $708.00+4.6% |
|
Oct 08
16:14 UTC
|
TRGP
Targa Resources
|
◎ Target | Theresa Chen ★★★☆☆ #1122 | Overweight | $284.00→ $294.00+3.5% |
|
Oct 08
16:14 UTC
|
TPG
TPG
|
◎ Target | Benjamin Budish ★★★☆☆ #1179 | Overweight | $64.00→ $60.00-6.2% |
|
Oct 08
16:14 UTC
|
STZ
Constellation Brands
|
◎ Target | Steve Powers not yet tracked | Hold | $136.00→ $127.00-6.6% |
|
Oct 08
16:14 UTC
|
SHLS
Shoals Technologies Group
|
◎ Target | Christine Cho ★★★☆☆ #1795 | Overweight | $10.00→ $11.00+10.0% |
|
Oct 08
16:14 UTC
|
RYTM
Rhythm Pharmaceuticals
|
◎ Target | Lisa Walter ★★☆☆☆ #2426 | Outperform | $155.00→ $159.00+2.6% |
|
Oct 08
16:14 UTC
|
LW
Lamb Weston
|
◎ Target | Andrew Lazar ★★★☆☆ #1333 | Overweight | $56.00→ $58.00+3.6% |
|
Oct 08
16:14 UTC
|
LEVI
Levi Strauss & Co.
|
◎ Target | Adrienne Yih ★★★☆☆ #1732 | Overweight | $27.00→ $26.00-3.7% |
|
Oct 08
16:14 UTC
|
KKR
KKR & Co. Inc.
|
◎ Target | Benjamin Budish ★★★☆☆ #1179 | Overweight | $135.00→ $130.00-3.7% |
|
Oct 08
16:14 UTC
|
CSTM
Constellium
|
◎ Target | Corinne Blanchard ★☆☆☆☆ #3135 | Buy | $39.00→ $36.00-7.7% |
|
Oct 08
16:14 UTC
|
CLH
Clean Harbors
|
◎ Target | William Grippin ★★★☆☆ #1879 | Equal Weight | $325.00→ $335.00+3.1% |
|
Oct 08
16:14 UTC
|
CG
Carlyle Group
|
◎ Target | Benjamin Budish ★★★☆☆ #1179 | Overweight | $64.00→ $53.00-17.2% |
|
Oct 08
16:14 UTC
|
BX
Blackstone
|
◎ Target | Benjamin Budish ★★★☆☆ #1179 | Equal Weight | $128.00→ $124.00-3.1% |
|
Oct 08
16:14 UTC
|
AEM
Agnico Eagle Mines
|
◎ Target | Daniel Major ★★★☆☆ #1478 | Neutral | $170.00→ $190.00+11.8% |
|
Oct 08
15:14 UTC
|
VRTX
Vertex Pharmaceuticals
|
◎ Target | Brian Abrahams ★★☆☆☆ #2490 | Outperform | $570.00→ $576.00+1.1% |
|
Oct 08
15:14 UTC
|
SAP
SAP
|
◎ Target | Keith Bachman ★★★★★ #150 | Outperform | $177.00→ $235.00+32.8% |
|
Oct 08
15:14 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Outperform | $251.00→ $259.00+3.2% |
|
Oct 08
15:14 UTC
|
ONC
BeOne Medicines
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Outperform | $450.00→ $459.00+2.0% |
|
Oct 08
15:14 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Lisa Walter ★★☆☆☆ #2426 | Outperform | $135.00→ $155.00+14.8% |
|
Oct 08
15:14 UTC
|
MGM
MGM Resorts International
|
◎ Target | Joseph Stauff ★★☆☆☆ #2821 | Positive | $46.00→ $41.00-10.9% |
|
Oct 08
15:14 UTC
|
MC
Moelis & Company
|
◎ Target | Ryan Kenny ★★★☆☆ #2037 | Overweight | $85.00→ $77.00-9.4% |
|
Oct 08
15:14 UTC
|
LEVI
Levi Strauss & Co.
|
◎ Target | Ike Boruchow ★★★★☆ #964 | Equal Weight | $25.00→ $20.00-20.0% |
|
Oct 08
15:14 UTC
|
LEGN
Legend Biotech
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Outperform | $58.00→ $56.00-3.4% |
|
Oct 08
15:14 UTC
|
LCLN
Lincoln International
|
◎ Target | Ryan Kenny ★★★☆☆ #2037 | Equal Weight | $28.00→ $27.00-3.6% |
|
Oct 08
15:14 UTC
|
LAZ
Lazard
|
◎ Target | Ryan Kenny ★★★☆☆ #2037 | Underweight | $44.00→ $41.00-6.8% |
|
Oct 08
15:14 UTC
|
KALU
Kaiser Aluminum
|
◎ Target | Samuel McKinney ★★★★☆ #356 | Overweight | $183.00→ $181.00-1.1% |
|
Oct 08
15:14 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Outperform | $299.00→ $296.00-1.0% |
|
Oct 08
15:14 UTC
|
INCY
Incyte
|
◎ Target | Brian Abrahams ★★☆☆☆ #2490 | Sec→ r Perform | $109.00→ $114.00+4.6% |
|
Oct 08
15:14 UTC
|
HRI
Herc
|
◎ Target | Jerry Revich ★★★☆☆ #1298 | Overweight | $218.00→ $176.00-19.3% |
|
Oct 08
15:14 UTC
|
HLI
Houlihan Lokey
|
◎ Target | Ryan Kenny ★★★☆☆ #2037 | Overweight | $177.00→ $165.00-6.8% |
|
Oct 08
15:14 UTC
|
FVR
FrontView REIT
|
◎ Target | Eric Borden ★★☆☆☆ #2341 | Outperform | $24.00→ $20.00-16.7% |
|
Oct 08
15:14 UTC
|
FLUT
Flutter Entertainment
|
◎ Target | Joseph Stauff ★★☆☆☆ #2821 | Positive | $115.00→ $100.00-13.0% |
|
Oct 08
15:14 UTC
|
EXEL
Exelixis
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Sec→ r Perform | $46.00→ $45.00-2.2% |
|
Oct 08
15:14 UTC
|
DKNG
DraftKings
|
◎ Target | Joseph Stauff ★★☆☆☆ #2821 | Positive | $33.00→ $27.00-18.2% |
|
Oct 08
15:14 UTC
|
CYTK
Cytokinetics
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Outperform | $112.00→ $113.00+0.9% |
|
Oct 08
15:14 UTC
|
CRS
Carpenter Technology
|
◎ Target | Samuel McKinney ★★★★☆ #356 | Overweight | $608.00→ $465.00-23.5% |
|
Oct 08
15:14 UTC
|
CMI
Cummins
|
◎ Target | Jerry Revich ★★★☆☆ #1298 | Overweight | $874.00→ $760.00-13.0% |
|
Oct 08
15:14 UTC
|
BLK
BlackRock
|
◎ Target | Michael Brown ★★★☆☆ #1460 | Overweight | $1,245.00→ $1,230.00-1.2% |
|
Oct 08
15:14 UTC
|
BKH
Black Hills
|
◎ Target | James Thalacker ★★★☆☆ #1717 | Outperform | $83.00→ $86.00+3.6% |
|
Oct 08
15:14 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Leonid Timashev ★★★☆☆ #1583 | Outperform | $297.00→ $295.00-0.7% |
|
Oct 08
15:14 UTC
|
ATI
ATI
|
◎ Target | Samuel McKinney ★★★★☆ #356 | Overweight | $258.00→ $228.00-11.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.